Amrize Ltd (NYSE:AMRZ – Get Free Report) announced a dividend on Thursday, October 29th. Investors of record on Tuesday, November 10th will be given a dividend of $0.11 per share on Wednesday, November 18th. The ex-dividend date of this dividend is Tuesday, November 10th.
Amrize Trading Up 3.9%
Shares of AMRZ stock opened at $41.60 on Friday. Amrize has a 12 month low of $35.78 and a 12 month high of $65.94. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average is $39.79 and its two-hundred day moving average is $50.68. The company has a market cap of $23.01 billion, a PE ratio of 18.82, a price-to-earnings-growth ratio of 1.42 and a beta of 0.20.
Amrize (NYSE:AMRZ – Get Free Report) last released its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 EPS for the quarter, meeting analysts’ consensus estimates of $1.05. The company had revenue of $3.77 billion for the quarter. Amrize had a net margin of 9.93% and a return on equity of 9.96%. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 EPS. Equities analysts predict that Amrize will post 2.44 EPS for the current year.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Barclays decreased their price target on shares of Amrize from $55.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday, October 19th. Deutsche Bank Aktiengesellschaft dropped their price objective on Amrize from $64.00 to $56.00 and set a “buy” rating on the stock in a research note on Wednesday, September 23rd. Oppenheimer cut their price objective on Amrize from $62.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, September 18th. Weiss Ratings downgraded Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, October 8th. Finally, Zacks Research lowered Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 19th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $49.12.
Get Our Latest Analysis on AMRZ
Amrize Company Profile
Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.
The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.
Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.
Featured Articles
- Five stocks we like better than Amrize
- 5 Stocks to Buy in November: Bargains Worth Giving Thanks For
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
